Grufity logoGrufity logo

Doximity, Inc. Stock Research

DOCS

32.51USD-0.40(-1.22%)Delayed

Market Summary

USD32.51-0.40
Delayed
-1.22%

DOCS Alerts

DOCS Stock Price

DOCS RSI Chart

DOCS Valuation

Market Cap

6.3B

Price/Earnings (Trailing)

52.85

Price/Sales (Trailing)

15.64

EV/EBITDA

46.11

Price/Free Cashflow

35.46

DOCS Price/Sales (Trailing)

DOCS Profitability

Operating Margin

87.16%

EBT Margin

30.95%

Return on Equity

12.78%

Return on Assets

11.14%

Free Cashflow Yield

2.82%

DOCS Fundamentals

DOCS Revenue

Revenue (TTM)

401.7M

Revenue Y/Y

17.76%

Revenue Q/Q

12.8%

DOCS Earnings

Earnings (TTM)

118.9M

Earnings Y/Y

-39.86%

Earnings Q/Q

27.26%

Price Action

52 Week Range

22.9154.69
(Low)(High)

Last 7 days

3.2%

Last 30 days

-2.2%

Last 90 days

-4.9%

Trailing 12 Months

-35.1%

DOCS Financial Health

Current Ratio

8.49

DOCS Investor Care

Shares Dilution (1Y)

2.59%

Diluted EPS (TTM)

0.55

Financials for Doximity

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue4.5%402384362344317
Gross Profit4.5%350335317304281
Operating Expenses5.6%230218206190172
  S&GA Expenses6.9%11610910192.0084.00
  R&D Expenses6.0%76.0072.0068.0062.0057.00
EBITDA5.0%133127118119113
EBITDA Margin0.5%0.33*0.33*0.33*0.35*0.36*
Earnings Before Taxes4.3%124119112114109
EBT Margin-0.2%0.31*0.31*0.31*0.33*0.34*
Net Income-15.7%119141151155140
Net Income Margin-19.4%0.30*0.37*0.42*0.45*0.44*
Free Cahsflow14.0%177155136125116
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets3.8%1,0671,0281,051991932
  Current Assets6.0%899848874904858
    Cash Equivalents85.2%13674.0011011385.00
  Net PPE-1.1%12.0012.0011.008.008.00
  Goodwill0%68.0068.0068.0019.0019.00
Liabilities-8.3%13714914911393.00
  Current Liabilities-10.4%10611812111192.00
Shareholder's Equity5.8%930879902879839
  Retained Earnings19.7%203170205191154
  Additional Paid-In Capital2.0%746731715703688
Accumulated Depreciation14.8%11.009.008.008.00-
Shares Outstanding0.5%193192193192188
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations13.5%180159138127117
  Share Based Compensation10.2%45.0041.0036.0031.0025.00
Cashflow From Investing35.6%-70.34-109-624-640-659
Cashflow From Financing-5.5%-58.21-55.192.00560558
  Buy Backs0.1%70.0070.009.003.004.00

Risks for DOCS

What is the probability of a big loss on DOCS?

84.8%


Probability that Doximity stock will be more than 20% underwater in next one year

82.6%


Probability that Doximity stock will be more than 30% underwater in next one year.

77.2%


Probability that Doximity stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does DOCS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Doximity was unfortunately bought at previous high price.

Drawdowns

Returns for DOCS

Cumulative Returns on DOCS

Which funds bought or sold DOCS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
reduced
-0.04
35,454
353,454
-%
2023-03-10
BAILLIE GIFFORD & CO
added
55.99
15,899,900
37,608,900
0.04%
2023-03-06
Rockefeller Capital Management L.P.
reduced
-64.84
-22,000
12,000
-%
2023-02-28
Voya Investment Management LLC
added
3.13
17,723,600
139,696,000
0.20%
2023-02-21
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
reduced
-87.27
-2,530
470
-%
2023-02-17
EQUITABLE TRUST CO
reduced
-17.44
-46,827
519,173
0.04%
2023-02-16
GHP Investment Advisors, Inc.
unchanged
-
517
2,517
-%
2023-02-16
HARBOUR INVESTMENTS, INC.
unchanged
-
-220
16,780
-%
2023-02-15
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
added
4.97
273,000
1,923,000
0.01%
2023-02-15
MetLife Investment Management, LLC
reduced
-84.02
-680,974
147,026
-%

1–10 of 42

Latest Funds Activity

Are funds buying DOCS calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own DOCS
No. of Funds

Doximity News

Marketscreener.com

Doximity Releases New Study on Physician Compensation and Impact of Overwork and Economic Pressures.

Marketscreener.com,
3 days ago

Nasdaq

The Motley Fool

Could AI Supercharge This Growth Stock?.

The Motley Fool,
15 days ago

Investopedia

The Motley Fool

The Motley Fool

Doximity Stock: Bear vs. Bull.

The Motley Fool,
20 days ago

Schedule 13G FIlings of Doximity

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Mar 08, 2023
blackrock inc.
4.5%
5,381,384
SC 13G/A
Feb 14, 2023
tangney jeffrey
31.5%
54,208,180
SC 13G/A
Feb 14, 2023
ameriprise financial inc
2.02%
2,294,675
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
2.9%
3,331,877
SC 13G/A
Feb 14, 2023
whale rock capital management llc
0.00%
0
SC 13G/A
Feb 13, 2023
emergence capital partners ii lp
15.1%
20,246,728
SC 13G/A
Feb 10, 2023
clearbridge investments, llc
5.1%
5,805,134
SC 13G
Feb 09, 2023
morgan stanley
13.3%
15,074,620
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
8.08%
9,169,268
SC 13G/A

DOCS Fair Value

Recent SEC filings of Doximity

View All Filings
Date Filed Form Type Document
Mar 08, 2023
SC 13G/A
Major Ownership Report
Feb 23, 2023
4
Insider Trading
Feb 23, 2023
4
Insider Trading
Feb 16, 2023
4
Insider Trading
Feb 16, 2023
4
Insider Trading
Feb 14, 2023
SC 13G/A
Major Ownership Report
Feb 14, 2023
5
Insider Trading
Feb 14, 2023
5
Insider Trading
Feb 14, 2023
SC 13G/A
Major Ownership Report
Feb 14, 2023
SC 13G/A
Major Ownership Report

Latest Insider Trading transactions for DOCS

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-02-21
EMERGENCE CAPITAL PARTNERS II LP
sold
-
-
-1,446,000
-
2023-02-21
EMERGENCE CAPITAL PARTNERS II LP
acquired
-
-
1,446,000
-
2023-02-21
Spain Kevin
sold
-
-
-1,446,000
-
2023-02-21
Spain Kevin
acquired
-
-
1,446,000
-
2023-02-15
Cabral Timothy S
acquired
-
-
7,500
-
2023-02-15
Cabral Timothy S
sold
-262,500
35.00
-7,500
-
2023-02-15
Jorgensen Paul W.
sold (taxes)
-44,680
33.17
-1,347
chief revenue officer
2023-02-14
Cabral Timothy S
acquired
-
-
10,000
-
2023-02-14
Cabral Timothy S
sold
-325,458
32.5458
-10,000
-
2023-02-02
Bryson Anna
sold
-1,000,000
40.00
-25,000
chief financial officer

1–10 of 50

Jeffrey A. Tangney
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

DOCS Income Statement

2022-09-30
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended6 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Revenue$ 102,185$ 79,350$ 192,824$ 152,019
Cost of revenue13,2108,95126,28716,937
Gross profit88,97570,399166,537135,082
Operating expenses:    
Research and development19,10415,46038,12628,701
Sales and marketing29,02121,16157,15540,532
General and administrative8,7498,82717,47316,023
Total operating expenses56,87445,448112,75485,256
Income from operations32,10124,95153,78349,826
Other income, net9084201,712465
Income before income taxes33,00925,37155,49550,291
Provision for (benefit from) income taxes6,710(10,717)6,813(12,119)
Net income26,29936,08848,68262,410
Undistributed earnings attributable to participating securities, basic000(18,326)
Undistributed earnings attributable to participating securities, diluted000(18,326)
Net income attributable to Class A and Class B common stockholders, basic26,29936,08848,68244,084
Net income attributable to Class A and Class B common stockholders, diluted$ 26,299$ 36,088$ 48,682$ 44,084
Net income per share attributable to Class A and Class B common stockholders:    
Basic (in dollars per share)$ 0.14$ 0.19$ 0.25$ 0.32
Diluted (in dollars per share)$ 0.12$ 0.17$ 0.23$ 0.27
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:    
Basic (in shares)193,137186,171193,042137,154
Diluted (in shares)213,949216,672214,452166,066

DOCS Balance Sheet

2022-09-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Mar. 31, 2022
Current assets:  
Cash and cash equivalents$ 73,674$ 112,809
Marketable securities676,317685,304
Accounts receivable, net of allowance for doubtful accounts of $427 and $359 at September 30, 2022 and March 31, 2022, respectively79,23681,073
Prepaid expenses and other current assets15,69119,439
Deferred contract costs, current2,9995,512
Total current assets847,917904,137
Property and equipment, net11,6478,488
Deferred income tax assets50,58348,558
Operating lease right-of-use assets14,8941,087
Intangible assets, net34,2327,909
Goodwill67,94018,915
Other assets1,1302,263
Total assets1,028,343991,357
Current liabilities:  
Accounts payable1,106463
Accrued expenses and other current liabilities26,40825,270
Deferred revenue, current89,61684,907
Operating lease liabilities, current1,013642
Total current liabilities118,143111,282
Deferred revenue, non-current16678
Operating lease liabilities, non-current14,625447
Contingent earn-out consideration liability, non-current15,4220
Other liabilities, non-current1,023956
Total liabilities149,379112,763
Commitments and contingencies (Note 12)
Stockholders' Equity  
Preferred stock, $0.001 par value; 100,000 shares authorized as of September 30, 2022 and March 31, 2022, respectively; zero shares issued and outstanding as of September 30, 2022 and March 31, 2022, respectively00
Class A and Class B common stock, $0.001 par value; 1,500,000 shares authorized as of September 30, 2022 and March 31, 2022, respectively; 192,302 and 192,398 shares issued and outstanding as of September 30, 2022 and March 31, 2022, respectively192192
Additional paid-in capital730,582702,589
Accumulated other comprehensive loss(21,559)(15,294)
Retained earnings169,749191,107
Total stockholders’ equity878,964878,594
Total liabilities and stockholders’ equity$ 1,028,343$ 991,357